Xiaosu Ma

23 papers receiving 899 citations

Xiaosu Ma's Hit Papers

Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial 2025 · 42 citations
420+1+2Years since publication100200300

Peers

Xiaosu Ma
Comparison fields: 5 of 65
  • Endocrinology, Diabetes and Metabolism 500
  • Pharmacology 172
  • Surgery 235
  • Physiology 116
  • Cardiology and Cardiovascular Medicine 80
Replace CHRISTOF M. KAZDA with:
CHRISTOF M. KAZDA United States
Günaj Rakipovski Denmark
Santiago Durán-Garcia Spain
Ted E. Okerson United States
CHRISTOPHER H. SORLI United States
Kenji Kohara Japan
Kexin Peng China
Lisa Musatti Italy
Rumi Kihara Japan
Ryoko Takei Japan
Xiaosu Ma relative to CHRISTOF M. KAZDA United States CHRISTOF M. KAZDA's profile →
Citations per field
00.5×2×3.0×
CHRISTOF M. KAZDA · 1×
Citations per year

Countries citing papers authored by Xiaosu Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaosu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosu Ma more than expected).

Fields of papers citing papers by Xiaosu Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaosu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosu Ma. The network helps show where Xiaosu Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaosu Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaosu Ma Line = papers co-authored together Xiaosu Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Hit paper breakdown →
2023323
2
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
Hit paper breakdown →
2023167
3
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
Hit paper breakdown →
2023133
4 202346
5
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
202542
6 202340
7 201429
8 202226
9 202422
10 200918
11 202515
12 201912
13 202411
14 20158
15 20196
16 20264
17 20254
18 20253
19 20202
20 20172

About Xiaosu Ma

Xiaosu Ma is a scholar working on Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology, Surgery, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 26 papers that have together received 917 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Gestational Diabetes Research and Management (3 papers), Lipid metabolism and disorders (3 papers), Diabetes Management and Research (3 papers), Bariatric Surgery and Outcomes (3 papers), Pancreatic function and diabetes (2 papers), Pharmacology and Obesity Treatment (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (500 citations), Pharmacology (172 citations), Surgery (235 citations), Physiology (116 citations) and Cardiology and Cardiovascular Medicine (80 citations). Xiaosu Ma has collaborated with scholars based in United States, Australia and Singapore. Frequent co-authors include Axel Haupt, Edward John Pratt, Deborah A. Robins, Маниге Кониг, Kieren J. Mather, CHRISTOF M. KAZDA, Julio Rosenstock, Sohini Raha, Sean Wharton and Rong Liu. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Diabetes Obesity and Metabolism, Journal of the American College of Cardiology, Journal of Diabetes Science and Technology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact